Literature DB >> 8050554

The European Community Respiratory Health Survey.

P G Burney1, C Luczynska, S Chinn, D Jarvis.   

Abstract

The European Community Respiratory Health Survey (ECRHS) was planned to answer specific questions about the distribution of asthma and health care given for asthma in the European Community. Specifically, the survey is designed to estimate variations in the prevalence of asthma, asthma-like symptoms and airway responsiveness; to estimate variations in exposures to known or suspected risk factors for asthma, and assess to what extent these variations explain the variations in the prevalence of disease; and to estimate differences in the use of medication for asthma. The protocol provides specific instructions on the sampling strategy adopted by the survey teams, as well as providing instructions on the use of questionnaires, the tests for allergy, lung function measurements, tests of airway responsiveness, and blood and urine collection. The principal data collection sheets and questionnaires are provided in the appendices, together with information on coding and quality control. The protocol is published as a reference for those who wish to know more of the methods used in the study, and also to give other groups who wish to collect comparable data access to the detailed methodology.

Entities:  

Mesh:

Year:  1994        PMID: 8050554     DOI: 10.1183/09031936.94.07050954

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  323 in total

1.  Social deprivation and patterns of consultation for respiratory symptoms: a population-based cohort study.

Authors:  P M Trinder; P R Croft; M Jones; G Thomas; J Bashford; M Dudgon
Journal:  J Epidemiol Community Health       Date:  1999-04       Impact factor: 3.710

2.  Two year follow up of pulmonary function values among welders in New Zealand.

Authors:  R Erkinjuntti-Pekkanen; T Slater; S Cheng; D Fishwick; L Bradshaw; M Kimbell-Dunn; L Dronfield; N Pearce
Journal:  Occup Environ Med       Date:  1999-05       Impact factor: 4.402

3.  Classification methods for the identification of 'case' in epidemiological diagnosis of asthma.

Authors:  M Grassi; S Villani; A Marinoni
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

4.  Wheeze not current asthma affects quality of life in young adults with asthma.

Authors:  M Matheson; J Raven; R K Woods; F Thien; E H Walters; M Abramson
Journal:  Thorax       Date:  2002-02       Impact factor: 9.139

5.  Respiratory morbidity in a population of French dental technicians.

Authors:  S Radi; J C Dalphin; P Manzoni; D Pernet; M P Leboube; J F Viel
Journal:  Occup Environ Med       Date:  2002-06       Impact factor: 4.402

6.  Association of CCR5Delta32 with reduced risk of childhood but not adult asthma.

Authors:  P Srivastava; P J Helms; D Stewart; M Main; G Russell
Journal:  Thorax       Date:  2003-03       Impact factor: 9.139

7.  Bronchial hyperresponsiveness in lung transplant recipients: lack of correlation with airway inflammation.

Authors:  P Liakakos; G I Snell; C Ward; D P Johns; T L Bamford; T J Williams; E H Walters
Journal:  Thorax       Date:  1997-06       Impact factor: 9.139

8.  Respiratory status in dairy farmers in France; cross sectional and longitudinal analyses.

Authors:  H Chaudemanche; E Monnet; V Westeel; D Pernet; A Dubiez; C Perrin; J-J Laplante; A Depierre; J-C Dalphin
Journal:  Occup Environ Med       Date:  2003-11       Impact factor: 4.402

Review 9.  Occupational exposure assessment in case-control studies: opportunities for improvement.

Authors:  K Teschke; A F Olshan; J L Daniels; A J De Roos; C G Parks; M Schulz; T L Vaughan
Journal:  Occup Environ Med       Date:  2002-09       Impact factor: 4.402

10.  An educational intervention to improve knowledge about prevention against occupational asthma and allergies using targeted maximum likelihood estimation.

Authors:  Daloha Rodríguez-Molina; Swaantje Barth; Ronald Herrera; Constanze Rossmann; Katja Radon; Veronika Karnowski
Journal:  Int Arch Occup Environ Health       Date:  2019-01-14       Impact factor: 3.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.